Health-care companies fell slightly as a rally in the defensive sector paused.

Obesity-drug maker Novo Nordisk slipped, but remains roughly 40% higher for the year to date.

Several attorneys general said consent judgments were filed in connection with Johnson & Johnson's $700 million settlement related to marketing of its talcum-based baby powder, confirming a tentative settlement unveiled in January.

U.S. Sen. Elizabeth Warren introduced a new bill to crack down on private-equity misconduct in the health-care sector, adding to the political pressure buyout firms face following numerous bankruptcies of hospital chains.

The European Union ordered more than 40 million bird flu vaccines from manufacturer CSL, as governments step up efforts to prevent the potential spread of the virus to people.

GSK said a plaintiff in an Illinois lawsuit against the company voluntarily dismissed her case, one of many legal disputes alleging its discontinued drug, Zantac, caused cancer.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

06-11-24 1809ET